search
Back to results

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

Primary Purpose

Hormone Disturbance, Endorphin Changes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vigorous Exercise
Sponsored by
Touro University Nevada
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hormone Disturbance

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Has reportedly experienced "runner's high" during vigorous exercise. Exclusion Criteria: Has not reportedly experienced "runner's high" during vigorous exercise.

Sites / Locations

  • Touro University Nevada

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Vigorous Exercise

Arm Description

50 Minutes of running on a treadmill

Outcomes

Primary Outcome Measures

Biochemical Changes in Blood Plasma
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Biochemical Changes in Blood Plasma
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Biochemical Changes in Blood Plasma
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot

Secondary Outcome Measures

Full Information

First Posted
March 6, 2023
Last Updated
July 24, 2023
Sponsor
Touro University Nevada
search

1. Study Identification

Unique Protocol Identification Number
NCT05790772
Brief Title
Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers
Official Title
Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2023 (Actual)
Primary Completion Date
May 1, 2023 (Actual)
Study Completion Date
July 23, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Touro University Nevada

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blood samples, the results will be analyzed for extracellular vesicles and biochemical changes within said extracellular vesicles.
Detailed Description
This study will recruit participants from the Touro University Nevada student body by placing flyers around campus and including announcements on the TUN screens. Program faculty will be encouraged to promote the study to their students through March. 20 male and female athletes who currently participate in regular endurance training will be recruited for the study. We will use men because the hormonal responses to exercise vary between men and women and is blunted at different points during the reproductive cycle. Participants recruited into the study will be normal weight (BMI or waist-to-hip ratio), and a history of regular participation in endurance training (see flyer). Participants will not have been diagnosed or treated for any psychiatric conditions, lower extremity or low back injury and will not have regularly taken any prescription medications within the past year. Participants will be consented into the study, scheduled, and given pre-participation instructions one week prior to the event. They will not take over-the-counter medications or supplements within one week of the trial, have no alcohol within 72 hours and no caffeine or nicotine within four hours, and no food within two hours of the protocol. Participants may drink water ad libitum prior to the trial. Upon arriving the day of the trial, participants will be screened by urinalysis for drug use. They will complete a survey based on the International Physical Activity Questionnaire which will be used to classify their history of physical activity. They will complete a pre-activity screen of their current emotional state using a set of Visual Analog Scales (VAS). On the day of the trial, participants will provide a urine sample for urinalysis. They will complete an electronic survey on their cell phone and will complete a paper survey including a set of visual analog scales. A butterfly needle will be inserted into their arm of choice which will allow the four small (5 ml) blood samples to be drawn throughout the activity. The first sample will be drawn immediately upon inserting the needle with subsequent draws performed at 50-minutes of physical activity, and the final draw 30-minutes after the activity ends. They will wear a heart monitor that will be used to monitor exercise intensity throughout the exercise protocol. Participants will complete an exercise protocol that includes 50 minutes of vigorous activity on a treadmill. They will be instructed to perform a 5-minute warm up and then begin running at a rate and treadmill elevation that ensures that they are working at 76-96% of their age-adjusted maximum heart rate. An attendant will monitor their heart rate throughout the protocol to ensure compliance. The participant will continue to exercise while blood is drawn at 50-minutes of activity. A butterfly needle will be inserted into the arm of their choice. A baseline sample of 5 ml of blood will be drawn immediately with subsequent 5 ml samples drawn at 25- and 50-minutes into the exercise protocol. A final 5 ml sample will be drawn at 30 minutes after completion of the protocol. The butterfly needle will be removed immediately after the final blood draw. The endorphin response has been documented at 70% of age-adjusted maximum heart rate and increases linearly after that. A heart monitor will be worn throughout the trial to monitor exercise intensity which will be determined based on the ACSM guidelines for vigorous exercise, 76-96% of the participant's age-adjusted maximum heart rate (AAMHR). Participants will be instructed to perform a 5-minute warm up and then begin running. A monitor will ensure that the participant maintains the target intensity throughout the activity. After completing the physical activity, participants will be offered healthy snacks while they walk, sit, or lie down anywhere within the lab. They will complete the second set of VAS ratings of emotional state that will be used to differentiate runners who experience "runner's high" from those who do not. The final 5 ml of blood will be drawn 30 minutes after completion of the exercise protocol after which the participant will take off the heart monitor and leave the lab. After collection of the blood samples, the results will be separated into blood plasma. The blood plasma will be analyzed for extracellular vesicles and quantitative biochemical changes within said extracellular vesicles.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hormone Disturbance, Endorphin Changes

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
20 Male and Female Athletes Aged 18-65
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Vigorous Exercise
Arm Type
Experimental
Arm Description
50 Minutes of running on a treadmill
Intervention Type
Behavioral
Intervention Name(s)
Vigorous Exercise
Intervention Description
50 minutes of running on a treadmill
Primary Outcome Measure Information:
Title
Biochemical Changes in Blood Plasma
Description
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Time Frame
0 minutes into exercising
Title
Biochemical Changes in Blood Plasma
Description
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Time Frame
50 minutes into exercising
Title
Biochemical Changes in Blood Plasma
Description
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Time Frame
30 minutes after completion of exercising

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Has reportedly experienced "runner's high" during vigorous exercise. Exclusion Criteria: Has not reportedly experienced "runner's high" during vigorous exercise.
Facility Information:
Facility Name
Touro University Nevada
City
Henderson
State/Province
Nevada
ZIP/Postal Code
89014
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data will be made anonymous to protect their identity as data analysis begins.

Learn more about this trial

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

We'll reach out to this number within 24 hrs